Trial · NCT04362072
Adverse events58
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 58
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Lorlatinib 100mg | 12 | 71 | |
| other | Diarrhoea | Gastrointestinal disorders | Lorlatinib 100mg | 13 | 71 | |
| other | Nausea | Gastrointestinal disorders | Lorlatinib 100mg | 6 | 71 | |
| other | Vomiting | Gastrointestinal disorders | Lorlatinib 100mg | 6 | 71 | |
| other | Asthenia | General disorders | Lorlatinib 100mg | 14 | 71 | |
| other | Fatigue | General disorders | Lorlatinib 100mg | 5 | 71 | |
| other | Oedema | General disorders | Lorlatinib 100mg | 6 | 71 | |
| other | Oedema peripheral | General disorders | Lorlatinib 100mg | 26 | 71 | |
| other | Pyrexia | General disorders | Lorlatinib 100mg | 12 | 71 | |
| other | COVID-19 | Infections and infestations | Lorlatinib 100mg | 8 | 71 | |
| other | Alanine aminotransferase increased | Investigations | Lorlatinib 100mg | 4 | 71 | |
| other | Blood cholesterol increased | Investigations | Lorlatinib 100mg | 19 | 71 | |
| other | Blood creatinine increased | Investigations | Lorlatinib 100mg | 5 | 71 | |
| other | Blood glucose increased | Investigations | Lorlatinib 100mg | 4 | 71 | |
| other | Blood triglycerides increased | Investigations | Lorlatinib 100mg | 16 | 71 | |
| other | SARS-CoV-2 test positive | Investigations | Lorlatinib 100mg | 5 | 71 | |
| other | Weight increased | Investigations | Lorlatinib 100mg | 7 | 71 | |
| other | Hypercholesterolaemia | Metabolism and nutrition disorders | Lorlatinib 100mg | 24 | 71 | |
| other | Hyperlipidaemia | Metabolism and nutrition disorders | Lorlatinib 100mg | 12 | 71 | |
| other | Hypertriglyceridaemia | Metabolism and nutrition disorders | Lorlatinib 100mg | 27 | 71 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04362072/events